The Cicada Vaccine Forecasting Engine and Guide
0.1.0 - ci-build
The Cicada Vaccine Forecasting Engine and Guide - Local Development build (v0.1.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
| Official URL: http://fhirfli.dev/fhir/ig/cicada/ValueSet/cdsi-observation-codes-vs | Version: 0.1.0 | |||
| Draft as of 2026-09-07 | Computable Name: CdsiObservationCodesVS | |||
Every CDSi observation code, as published in the supporting data.
References
This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes version 📦0.1.0
Expansion performed internally based on codesystem CDSI Observation Codes v0.1.0 (CodeSystem)
This value set contains 278 concepts
| System | Code | Display (en) | JSON | XML |
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 001 | Patient seeks protection | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 002 | Undergoing elective splenectomy | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 003 | Immunocompromised | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 004 | Recipient of a hematopoietic stem cell transplant | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 005 | Hepatitis C virus infection | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 006 | Receives clotting factor concentrates | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 007 | Pregnant | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 008 | Travel to an area of active cholera transmission | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 009 | Breastfeeding | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 010 | Cerebrospinal fluid leaks | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 011 | Cochlear implants | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 012 | Family history of altered immunocompetence | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 013 | Severe Combined Immunodeficiency [SCID] | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 014 | Diabetes | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 015 | Chronic liver disease | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 016 | Chronic heart disease | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 017 | Chronic lung disease | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 018 | Laboratory Evidence of Immunity or confirmation of Hepatitis A disease | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 019 | Laboratory Evidence of Immunity or confirmation of Hepatitis B disease | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 020 | Laboratory Evidence of Immunity for Measles | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 021 | Laboratory Evidence of Immunity for Mumps | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 022 | Laboratory Evidence of Immunity for Rubella | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 023 | Laboratory Evidence of Immunity or confirmation of Varicella disease | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 024 | Healthcare provider verified history of or diagnosis of Varicella | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 025 | Healthcare provider verified history or diagnosis of Herpes Zoster | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 026 | Persons with perinatal HIV infection who do not have evidence of severe immunosuppression and who were vaccinated with MMR before establishment of antiviral therapy [ART] | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 027 | Asthma | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 028 | Intussusception | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 029 | Acute gastroenteritis | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 030 | Acute febrile illness | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 031 | Tuberculosis | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 032 | Dialysis patient | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 033 | Taken influenza antiviral medications within the previous 48 hours | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 034 | Receiving long-term aspirin therapy | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 035 | Antimicrobial or antimalarial taken within 72 hours | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 036 | Men who have sex with men | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 037 | Not in a long-term, mutually monogamous relationship | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 038 | Sex partner of Hepatitis B surface antigen-positive persons | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 039 | Receives treatment for STD | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 040 | Illicit drug use | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 041 | Illicit injection drug use | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 042 | Smoke cigarettes | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 043 | Alcoholism | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 044 | Anticipate close personal contact with international adoptee | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 045 | Travel to country with a Yellow Fever vaccination entry requirement | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 046 | College students living in residence halls | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 047 | Resident of area at risk for exposure to the disease | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 048 | Travelling Internationally | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 049 | Working with Hepatitis A virus in research setting | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 050 | Microbiologists routinely exposed to Neisseria meningitidis | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 051 | Microbiology laboratorians who work frequently with S. typhi | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 052 | Laboratory personnel who might be exposed to YFV | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 053 | Rabies researchers | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 054 | Laboratory workers who handle specimens that might contain polioviruses | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 055 | Health care personnel | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 056 | Health-care workers who have close contact with patients who might be excreting wild polioviruses | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 057 | Public safety worker exposed to blood or infection body fluids | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 058 | Staff of institution for persons with developmental disabilities | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 059 | Occupational exposure for Hepatitis A | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 060 | Veterinarians and their staff | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 061 | Animal handlers | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 062 | Persons whose activities bring them into frequent contact with rabies virus or potentially rabid animals | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 063 | Post secondary student | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 064 | Military recruits | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 065 | Client of institution for persons with developmental disabilities | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 066 | Chronic renal failure | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 068 | In drug abuse treatment and prevention facility | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 069 | In correctional facility | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 070 | Persons at risk during an outbreak | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 071 | Household contact with hepatitis B surface antigen-positive persons | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 072 | Intimate exposure to a documented S. typhi carrier | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 073 | Household and close contacts of immunocompromised persons | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 074 | Negative serological screening for varicella | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 075 | Transgender person | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 076 | Progressive neurologic disorder | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 077 | Received inactivated or unknown measles vaccine between 1963-1967 | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 078 | Received killed or unknown Mumps vaccine before 1979 | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 079 | Encephalopathy not attributable to another identifiable cause within 7 days of administration of a previous dose of Tdap, DTP, or DTaP vaccine | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 080 | Adverse reaction to vaccine component | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 081 | Severe allergic reaction after previous dose of Polio | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 082 | Severe allergic reaction after previous dose of Japanese Encephalitis | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 083 | Severe allergic reaction after previous dose of Rotavirus | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 084 | Severe allergic reaction after previous dose of Typhoid | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 085 | Severe allergic reaction after previous dose of Influenza | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 086 | Severe allergic reaction after previous dose of Pertussis | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 087 | Severe allergic reaction after previous dose of Diphtheria | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 088 | Severe allergic reaction after previous dose of Tetanus | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 089 | Severe allergic reaction after previous dose of Varicella | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 090 | Severe allergic reaction after previous dose of HPV | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 091 | Severe allergic reaction after previous dose of Measles | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 092 | Severe allergic reaction after previous dose of Mumps | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 093 | Severe allergic reaction after previous dose of Rubella | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 094 | Severe allergic reaction after previous dose of Pneumococcal | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 095 | Severe allergic reaction after previous dose of Meningococcal | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 096 | Severe allergic reaction after previous dose of Hepatitis A | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 097 | Severe allergic reaction after previous dose of Hepatitis B | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 098 | Severe allergic reaction after previous dose of Hib | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 099 | Severe allergic reaction after previous dose of Yellow Fever | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 100 | Severe allergic reaction after previous dose of live zoster | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 101 | Allergic reaction to egg protein | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 102 | Severe allergic reaction to gelatin | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 103 | Severe allergic reaction to arginine | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 104 | Allergic reaction to latex | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 105 | Severe allergic reaction to chicken protein | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 106 | Severe allergic reaction to gentamicin | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 107 | Severe allergic reaction to neomycin | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 108 | Severe allergic reaction to streptomycin | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 109 | Severe allergic reaction to polymyxin B | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 110 | Hypersensitivity to yeast | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 111 | Hypersensitivity to the preservative 2-phenoxyethanol | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 112 | Hypersensitivity to alum | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 113 | Severe allergic reaction after previous dose of Rabies | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 114 | End stage renal disease | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 115 | Severe allergic reaction to protamine sulfate | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 116 | Severe allergic reaction after previous dose of Meningococcal B | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 117 | Severe allergic reaction to diphtheria toxoid | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 118 | Severe allergic reaction to tetanus toxoid | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 119 | Severe allergic reaction after previous dose of cholera | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 120 | Begin Date of antiviral therapy [ART] | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 121 | Homelessness | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 122 | Severe allergic reaction after previous dose of COVID-19 | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 123 | Severe allergic reaction after previous dose of Ebola | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 124 | Severe allergic reaction to rice protein | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 125 | Tetanus IG administration | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 126 | Hep A IG administration | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 127 | Hep B IG administration | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 128 | Rabies IG administration | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 129 | Varicella IG administration | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 130 | Measles prophylaxis IG administration - Standard | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 131 | Measles prophylaxis IG administration - Immunocompromised Contact | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 132 | RBC [adenine-saline added] blood transfusion | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 133 | Packed RBC blood transfusion | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 134 | Whole blood transfusion | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 135 | Plasma/platelet products blood transfusion | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 136 | Cytomegalovirus IGIV | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 137 | IGIV - Replacement therapy for immune deficiencies | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 138 | IGIV - Immune thrombocytopenic purpura treatment | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 139 | IGIV - Postexposure varicella prophylaxis | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 140 | IGIV - Immune thrombocytopenic purpura treatment | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 141 | IGIV - Kawasaki disease | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 142 | Travel to or working in countries that have high or intermediate endemicity of Hepatitis A | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 143 | Travel to areas or countries where polio is epidemic or endemic | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 144 | International travel with possible contact with animals in areas where rabies is enzootic and immediate access to appropriate medical care might be limited | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 145 | B-lymphocyte [humoral] - Severe antibody deficiencies | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 146 | B-lymphocyte [humoral] - Less severe antibody deficiencies | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 147 | T-lymphocyte [cell-mediated and humoral] - Complete defects | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 148 | T-lymphocyte [cell-mediated and humoral] - Partial defects | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 149 | T-lymphocyte [cell-mediated and humoral] - interferon-gamma/Interleukin 12 axis deficiencies | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 150 | T-lymphocyte [cell-mediated and humoral] - interferon-gamma or interferon-alpha deficiencies | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 151 | Persistent complement, properdin, or factor B deficiency | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 152 | Phagocytic function - Chronic granulomatous disease | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 153 | Phagocytic function - Leukocyte adhesion defect, and myeloperoxidase deficiency | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 154 | HIV/AIDS - severely immunocompromised | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 155 | HIV/AIDS - not severely immunocompromised | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 156 | Generalized malignant neoplasm | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 157 | Solid organ transplantation | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 158 | Immunosuppressive therapy | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 159 | Radiation therapy | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 160 | Anatomical or functional asplenia | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 161 | Chronic kidney disease | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 162 | Travel to areas at risk for Yellow Fever transmission | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 163 | Travel to areas in which there is a recognized risk of exposure to S. typhi | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 164 | Travel to or are residents of countries in which meningococcal disease is hyperendemic or epidemic | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 165 | Longer-term (e.g., 1 month or more) travel to a JE-endemic area | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 166 | Travel to countries with high or intermediate prevalence of chronic HBV infection | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 167 | Nephrotic Syndrome | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 168 | Chemotherapy | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 169 | History of sexual abuse or assault | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 170 | Onset of pregnancy | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 171 | Date of hematopoietic stem cell transplant | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 172 | Severe allergic reaction after previous dose of recombinant zoster | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 173 | Moving to JE-endemic country to take up residence | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 174 | Frequent travel to JE-endemic areas | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 175 | Patient seeks Hepatitis A protection | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 176 | Patient seeks Hepatitis B protection | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 177 | Patient seeks Meningococcal B protection | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 178 | Leukemia | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 179 | Lymphoma | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 180 | Hodgkin's disease | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 181 | Multiple myeloma | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 182 | Ebola virus outbreak response | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 183 | Health care personnel at federally designated Ebola treatment center in U.S. | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 184 | Laboratorians or other staff at biosafety level 4 facilities in U.S. | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 185 | Persons in settings that provide services to adults with high proportion of those persons have risk factors for HAV infection | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 186 | HIV Infection | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 187 | Allergic reaction to polysorbate 80 | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 188 | Known allergy to Polyethylene glycol [PEG] | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 189 | Active treatment for solid tumors | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 190 | Active treatment for hematologic malignancies | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 191 | Receipt of CAR-T-cell therapy | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 192 | Severe allergic reaction after previous dose of any egg-based IIV or LAIV influenza vaccine | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 193 | Severe allergic reaction after previous dose of any ccIIV influenza vaccine | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 194 | Severe allergic reaction after previous dose of any RIV influenza vaccine | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 195 | Occupations at increased risk for COVID-19 exposure and transmission | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 196 | Residing in an institutional setting at increased risk for COVID-19 exposure and transmission | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 197 | Resident of a long term care facility | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 198 | Cancer | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 199 | Interstitial lung disease | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 200 | Cystic fibrosis | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 201 | Pulmonary hypertension | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 202 | Dementia | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 203 | Down syndrome | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 204 | Obesity | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 205 | Thalassemia | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 206 | Cerebrovascular disease | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 207 | Substance use disorder | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 208 | Mental Health conditions | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 209 | History of thrombosis with thrombocytopenia following the Janssen COVID-19 Vaccine or any other adenovirus-vectored COVID-19 vaccines | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 210 | Severe allergic reaction after previous dose of Dengue vaccine | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 211 | Evidence of previous dengue infection and living in areas where dengue is endemic | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 212 | Health care personnel involved in the care and transport of patients with suspected or confirmed Ebola virus disease at Special Pathogen Treatment Centers | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 213 | Laboratorians and support staff members at Laboratory Response Network (LRN) facilities that handle specimens that might contain replication-competent Ebola virus in the United States | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 214 | Chronic obstructive pulmonary disease | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 215 | Emphysema | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 216 | Iatrogenic Immunosuppression | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 217 | Persons working in rabies vaccine production facilities | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 218 | Persons performing testing for rabies in diagnostic laboratories | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 219 | Persons who frequently handle bats | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 220 | Persons who frequently have contact with bats | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 221 | Persons who frequently enter high-density bat environments | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 222 | Persons who frequently perform animal necropsies | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 223 | Severe allergic reaction after previous dose of orthopoxvirus vaccine | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 224 | History or presence of atopic dermatitis | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 225 | Household contact with history or presence of atopic dermatitis | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 226 | Active exfoliative skin conditions | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 227 | Household contact with active exfoliative skin conditions | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 228 | Household contact is pregnant | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 229 | Age is less than 1 year | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 230 | Household contact who is less than 1 year of age | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 231 | 3 or more known major cardiac risk factors | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 232 | Research laboratory personnel working with more virulent orthopoxviruses (e.g., Variola virus or mpox virus) | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 233 | Clinical laboratory personnel performing diagnostic testing for more virulent orthopoxviruses (e.g., Variola virus or mpox virus) | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 234 | Designated response team members working with more virulent orthopoxviruses (e.g., Variola virus or mpox virus) | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 235 | Healthcare personnel who care for patients infected with more virulent orthopoxviruses (e.g., Variola virus or mpox virus) | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 236 | Research laboratory personnel working with less virulent orthopoxviruses (e.g., Vaccinia virus or Cowpox virus) | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 237 | Clinical laboratory personnel performing diagnostic testing for less virulent orthopoxviruses (e.g., Vaccinia virus or Cowpox virus) | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 238 | Designated response team members working with less virulent orthopoxviruses (e.g., Vaccinia virus or Cowpox virus) | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 239 | Healthcare personnel who administer ACAM2000 | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 240 | Healthcare personnel who care for patients infected with less virulent orthopoxviruses (e.g., Vaccinia virus or Cowpox virus) | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 241 | Known exposure to mpox | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 242 | Presumed exposure to mpox | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 243 | Lack of laboratory confirmation of a previous Dengue infection | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 244 | Severe allergic reaction after previous dose of RSV vaccine | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 245 | American Indian or Alaskan Native | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 246 | Severe immunocompromise | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 247 | Gay, bisexual, or other man who has sex with men (MSM), or a person who has sex with gay, bisexual, or other MSM who in the past 6 months have had one of the following: 1) A new diagnosis of ≥ 1 sexually transmitted disease 2) More than one sex partner 3) Sex at a commercial sex venue 4) Sex in association with a large public event in a geographic area where mpox transmission is occurring | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 248 | Sexual partners of gay, bisexual, or other man who has sex with men (MSM), or a person who has sex with gay, bisexual, or other MSM who in the past 6 months have had one of the following: 1) A new diagnosis of ≥ 1 sexually transmitted disease 2) More than one sex partner 3) Sex at a commercial sex venue 4) Sex in association with a large public event in a geographic area where mpox transmission is occurring | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 249 | Moving or traveling to an area where TBE is endemic and will have extensive exposure to ticks because of their planned outdoor activities and itinerary | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 250 | Moving or traveling to an area where TBE is endemic who might engage in outdoor activities in areas where ticks are likely to be found | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 251 | Laboratory workers with a potential for exposure to TBE virus | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 252 | Severe allergic reaction after previous dose of Tick-borne Encephalitis vaccine | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 253 | Moderate persistent or severe persistent asthma | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 254 | Chronic cardiovascular disease | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 256 | Diabetes mellitus complicated by chronic kidney disease | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 257 | Severe obesity | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 258 | Chronic hematologic disorders | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 259 | Sickle cell disease | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 260 | Neurologic or neuromuscular conditions causing impaired airway clearance or respiratory muscle weakness | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 261 | Resident of a nursing home | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 262 | Frailty | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 263 | Diabetes mellitus complicated by neuropathy | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 264 | Diabetes mellitus complicated by retinopathy | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 265 | Diabetes mellitus complicated by end-organ damage | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 266 | Diabetes requiring treatment with insulin | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 267 | Diabetes requiring treatment with sodium-glucose cotransporter-2 (SGLT2) inhibitor | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 268 | Islet Transplantation | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 269 | Transplantation | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 270 | Severe allergic reaction after previous dose of Chikungunya vaccine | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 271 | Traveling to a country or territory where there is a chikungunya outbreak | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 272 | Traveling or moving to a country or territory without an outbreak but with elevated chikungunya risk for U.S. travelers if planning to stay for an extended period of time [e.g., 6 months or more] | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 273 | Immunoglobulin deficiency | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 274 | Early component complement inhibitor use | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 275 | Persons at risk during a measles outbreak | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 276 | Age is 60 years or older | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 277 | Laboratory worker with potential for exposure to chikungunya virus | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 278 | Birth mother received RSV vaccine during pregnancy | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 279 | Hemoglobinopathy disorder | ||
http://fhirfli.dev/fhir/ig/cicada/CodeSystem/cdsi-observation-codes | 280 | Chronic lung disease of prematurity |
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |